References
- Barnes A. J., Locke P., Scudder P. R., Dormandy T. L., Dormandy J. A., Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease?. Lancet 1977; 2: 789
- Buchanan N., Moodley G. P. The effect of pentoxifyl-line on human erythrocyte adenosine triphosphate. IRCS Medical Sciences 1977; 5: 43
- Cooper R. A. Abnormalities of cell-membrane fluidity in the pathogenesis of disease. New Engl. J. Med 1977; 297: 371
- Ehrly A. M., Kohler H.-J. Altered deformability of erythrocytes from patients with chronic occlusive arterial disease. VASA 1976; 5: 319
- Itoh T., Satoh T. Influence of pentoxifylline (Trental) on platelet aggregation and serum lipids in patients with obstructive cerebrovascular disorders. Pharmatherapeuti-ca 1979; 2: 159
- Johnsson R. Effect of pentoxifylline on red cell flexibility and cation transport in healthy subjects and patients with hereditary spherocytosis. Scand. J. Haematol 1979; 23: 81
- Johnsson R., Vuopio P. Studies on red cell flexibility in spherocytosis using a polycarbonate membrane filtration method. Acta Haematol. Basel 1978; 60: 329
- Katsunuma, et al. Influence of pentoxifylline on erythro-cyt membrane in aged C. V.D. patients. The 3rd General Meeting of the Japanese Society of Stroke, Akita June, 1978; 8–10, Report No. 223
- Mc Millan D. E., Utterback N. G., La Puma J. Reduced erythrocyte deformability in diabetes. Diabetes 1978; 27: 895
- Martin P. Déformabilité des globules rouges et accidents vasculaires cérébraux intérêt de la pentoxifylline. Gazette médicale de France 1979; 86: 2585
- Reid H. L., Dormandy J. A., Barnes A. J., Lock P. J., Dormandy T. L. Impaired red cell deformability in peripheral vascular disease. Lancet 1976; 1: 666
- Schmid-Schönbein H., Volger E. Red-cell aggregation and red-cell deformability in diabetes. 1976; 25: 897, Suppl. 2